Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > We have all been had...
View:
Post by ETalien on Dec 01, 2020 12:02pm

We have all been had...

Still halted... TD is asking to get rid of the stock that has no value... the only one I have that has no value... Kalytera! So TD must know something. 

I feel BANKRUPTCY is on the horizon... 
or restructuring meaning all retail investors are boned and the insiders get their palm greased as what usually occurs in a restructuring/bankruptcy. 

...my take!

Comment by Scotty on Dec 01, 2020 1:54pm
It wouldn't shock me at all if KLY decided to cease operations. Only a RS and further dilution in the future to fund drug trials for another company. With over 500m outstanding shares and no revenue are there any other options? It would be hilarious if KLY did shut down and Bob started a new company with the current licensing agreement with Salz as it's only "asset". It would ...more  
Comment by JamesBondage007 on Dec 03, 2020 12:55pm
Odd though why gift it to them?? I'd rather give it to donation.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities